These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1937 related items for PubMed ID: 7804531

  • 1. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
    Nishimura MI, Kawakami Y, Charmley P, O'Neil B, Shilyansky J, Yannelli JR, Rosenberg SA, Hood L.
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):85-94. PubMed ID: 7804531
    [Abstract] [Full Text] [Related]

  • 2. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 3. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
    Shilyansky J, Nishimura MI, Yannelli JR, Kawakami Y, Jacknin LS, Charmley P, Rosenberg SA.
    Proc Natl Acad Sci U S A; 1994 Mar 29; 91(7):2829-33. PubMed ID: 7511820
    [Abstract] [Full Text] [Related]

  • 4. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.
    Cancer Res; 1997 Dec 01; 57(23):5320-7. PubMed ID: 9393756
    [Abstract] [Full Text] [Related]

  • 5. Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes.
    Sensi M, Castelli C, Salvi S, Mazzocchi A, Mortarini R, Nicolini G, Anichini A, Parmiani G.
    J Immunother (1991); 1992 Oct 01; 12(3):207-11. PubMed ID: 1332745
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
    Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, Mortarini R, Rivoltini L, Farina C, Nicolini G, Wölfel T.
    Proc Natl Acad Sci U S A; 1995 Jun 06; 92(12):5674-8. PubMed ID: 7777568
    [Abstract] [Full Text] [Related]

  • 7. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J, Birck A, Straten PT.
    Arch Immunol Ther Exp (Warsz); 1995 Jun 06; 43(2):123-33. PubMed ID: 8744727
    [Abstract] [Full Text] [Related]

  • 8. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient.
    Mandruzzato S, Rossi E, Bernardi F, Tosello V, Macino B, Basso G, Chiarion-Sileni V, Rossi CR, Montesco C, Zanovello P.
    J Immunol; 2002 Oct 01; 169(7):4017-24. PubMed ID: 12244204
    [Abstract] [Full Text] [Related]

  • 9. Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene families.
    Sensi M, Castelli C, Anichini A, Grossberger D, Mazzocchi A, Mortarini R, Parmiani G.
    Melanoma Res; 1991 Oct 01; 1(4):261-71. PubMed ID: 1668534
    [Abstract] [Full Text] [Related]

  • 10. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL.
    Int J Cancer; 1993 May 28; 54(3):383-90. PubMed ID: 8509212
    [Abstract] [Full Text] [Related]

  • 11. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
    Schøller J, thor Straten P, Birck A, Siim E, Dahlström K, Drzewiecki KT, Zeuthen J.
    Cancer Immunol Immunother; 1994 Oct 28; 39(4):239-48. PubMed ID: 7954526
    [Abstract] [Full Text] [Related]

  • 12. Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.
    Fisk B, Flytzanis CN, Pollack MS, Wharton JT, Ioannides CG.
    Scand J Immunol; 1994 Dec 28; 40(6):591-600. PubMed ID: 7848491
    [Abstract] [Full Text] [Related]

  • 13. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P, Schøller J, Hou-Jensen K, Zeuthen J.
    Int J Cancer; 1994 Jan 02; 56(1):78-86. PubMed ID: 8262682
    [Abstract] [Full Text] [Related]

  • 14. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS, Topalian SL, Simonis T, Mancini M, Rosenberg SA.
    J Immunother (1991); 1991 Jun 02; 10(3):153-64. PubMed ID: 1868040
    [Abstract] [Full Text] [Related]

  • 15. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ, Weil DP, Shamamian P, Rivoltini L, Kawakami Y, Topalian S, Jennings C, Eliyahu S, Rosenberg SA, Nishimura MI.
    Cancer Res; 1994 Oct 15; 54(20):5265-8. PubMed ID: 7522957
    [Abstract] [Full Text] [Related]

  • 16. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
    Nishimura MI, Custer MC, Schwarz SL, Parker LL, Mixon A, Clay TM, Yannelli JR, Rosenberg SA.
    J Immunother; 1998 Sep 15; 21(5):352-62. PubMed ID: 9789197
    [Abstract] [Full Text] [Related]

  • 17. Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma.
    Ebato M, Nitta T, Yagita H, Sato K, Okumura K.
    Immunol Lett; 1993 Dec 15; 39(1):53-64. PubMed ID: 8144191
    [Abstract] [Full Text] [Related]

  • 18. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
    Kan-Mitchell J, Huang XQ, Steinman L, Oksenberg JR, Harel W, Parker JW, Goedegebuure PS, Darrow TL, Mitchell MS.
    Cancer Immunol Immunother; 1993 Jul 15; 37(1):15-25. PubMed ID: 8513449
    [Abstract] [Full Text] [Related]

  • 19. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE, Davey MP, Goedegebuure PS, Schoof DD, Eberlein TJ.
    J Immunol; 1993 Nov 15; 151(10):5472-80. PubMed ID: 8228239
    [Abstract] [Full Text] [Related]

  • 20. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
    Strohal R, Paucz L, Pehamberger H, Stingl G.
    Cancer Res; 1994 Sep 01; 54(17):4734-9. PubMed ID: 8062272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.